Jason A Stannard

Title: Innovations by Jason A. Stannard

Introduction

Jason A. Stannard is an accomplished inventor based in San Diego, California. He has made significant contributions to the field of biomedical research, particularly in the measurement of bioactive human hepcidin levels. With a total of two patents to his name, Stannard's work has the potential to impact various aspects of health and disease management.

Latest Patents

Stannard's latest patents focus on compositions and methods for measuring levels of bioactive human hepcidin. The first patent provides methods for the oxidative refolding of a hepcidin polypeptide to achieve a mature, bioactive form that resembles its native configuration. This invention also includes a method for measuring the level of native, bioactive hepcidin in vertebrate animals. The second patent elaborates on similar methodologies, emphasizing the measurement of hepcidin gene expression and the regulation of hepcidin production in vivo. Additionally, it introduces an antibody that specifically binds to hepcidin, along with a pharmaceutical composition that offers antimicrobial, agonistic, or antagonistic activities in vertebrate animals.

Career Highlights

Stannard is currently associated with Intrinsic Lifesciences LLC, where he continues to advance his research and innovations. His work is pivotal in understanding the role of hepcidin in various biological processes and diseases.

Collaborations

Stannard collaborates with notable colleagues, including Xavier Lauth and Mark Westerman. Their combined expertise enhances the research and development efforts at Intrinsic Lifesciences LLC.

Conclusion

Jason A. Stannard's contributions to the field of biomedical research through his innovative patents on hepcidin measurement are noteworthy. His work not only advances scientific understanding but also holds promise for future therapeutic applications.